Blegdamsvej 3, 2200 København N, Bygning 6, Bygning: 06-6-62
Matthias Mann is Research Director and Group leader at the Proteomics Program at Novo Nordisk Foundation Center for Protein Research (CPR, www.cpr.ku.dk) at the University of Copenhagen. He also holds a Director position at the Max-Planck Institute of Biochemistry in Munich. Matthias Mann is one of the most highly cited researchers in the world with h-index 216 and more than 200,000 citations. He is a pioneer of mass spectrometry-based proteomics and has made landmark contributions to the development of electrospray ionization. He has also contributed to making mass spectrometry applicable to molecular biology, including by developing computer algorithms to connect mass-spectrometric data with sequence databases.
Matthias Mann and his teams work in proteomics technology development and applying that technology to biological and clinical problems. Their large-scale proteomics and phosphoproteomics studies have shed light on a wide variety of questions in the life sciences. The focus of the Clinical Proteomics group at CPR is to identify biological markers for diabetes, obesity and other metabolic disorders. The group has already established robust and reproducible high-throughput proteomics workflows, are routinely applied for proteomic screening of clinical cohorts.